The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by IFM Investors Pty Ltd

IFM Investors Pty Ltd boosted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 10.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 43,162 shares of the medical device company's stock after buying an additional 4,224 shares during the quarter. IFM Investors Pty Ltd's holdings in Cooper Companies were worth $3,641,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of COO. OFI Invest Asset Management acquired a new stake in shares of Cooper Companies during the fourth quarter worth $34,000. City Holding Co. acquired a new stake in shares of Cooper Companies during the first quarter worth $34,000. New Age Alpha Advisors LLC acquired a new position in Cooper Companies during the fourth quarter valued at $38,000. Covestor Ltd lifted its position in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares during the period. Finally, Atala Financial Inc acquired a new position in Cooper Companies during the fourth quarter valued at $51,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of research reports. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Needham & Company LLC raised shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price objective for the company in a research note on Tuesday, June 17th. Robert W. Baird decreased their target price on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a report on Friday, May 30th. Wells Fargo & Company decreased their target price on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a report on Friday, May 30th. Finally, Wall Street Zen upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $99.70.

Cooper Companies Stock Up 1.3%

Shares of NASDAQ COO traded up $0.97 during mid-day trading on Tuesday, reaching $74.26. The company had a trading volume of 2,786,074 shares, compared to its average volume of 1,723,958. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The firm has a 50 day simple moving average of $75.45 and a two-hundred day simple moving average of $83.06. The stock has a market cap of $14.85 billion, a P/E ratio of 36.05, a PEG ratio of 1.79 and a beta of 0.99. The Cooper Companies, Inc. has a 52-week low of $65.00 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company's revenue was up 6.3% on a year-over-year basis. During the same period last year, the firm posted $0.85 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.